Orexinergic System Dysregulation, Sleep Impairment, and Cognitive Decline in Alzheimer Disease
Claudio Liguori,Andrea Romigi,Marzia Nuccetelli,S. Zannino,Giuseppe Sancesario,Alessandro Martorana,Maria Albanese,Nicola Biagio Mercuri,Francesca Izzi,Sergio Bernardini,Alessandra Nitti,Giulia Maria Sancesario,Francesco Sica,Maria Grazia Marciani,Fabio Placidi +14 more
TLDR
The results demonstrate that, in AD, increased cerebrospinal fluid orexin levels are related to a parallel sleep deterioration, which appears to be associated with cognitive decline.Abstract:
Importance Nocturnal sleep disruption develops in Alzheimer disease (AD) owing to the derangement of the sleep-wake cycle regulation pathways. Orexin contributes to the regulation of the sleep-wake cycle by increasing arousal levels and maintaining wakefulness. Objectives To study cerebrospinal fluid levels of orexin in patients with AD, to evaluate the relationship of orexin cerebrospinal fluid levels with the degree of dementia and the cerebrospinal fluid AD biomarkers (tau proteins and β-amyloid 1-42), and to analyze potentially related sleep architecture changes measured by polysomnography. Design, setting, and participants We conducted a case-control study from August 1, 2012, through May 31, 2013. We included 48 drug-naive AD patients referred to the Neurological Clinic of the University Hospital of Rome Tor Vergata. Based on the Mini-Mental State Examination score, 21 patients were included in mild AD group (score, ≥21), whereas 27 were included in the moderate to severe AD group (score, Exposure Laboratory assessment of cerebrospinal fluid levels of orexin, tau proteins, and β-amyloid 1-42 and polysomnographic assessment of sleep variables. Main outcomes and measures Levels of orexin, tau proteins, and β-amyloid 1-42; macrostructural variables of nocturnal sleep (total sleep time, sleep efficiency, sleep onset and rapid eye movement [REM] sleep latencies, non-REM and REM sleep stages, and wakefulness after sleep onset); and Mini-Mental State Examination scores. Results Patients with moderate to severe AD presented with higher mean (SD) orexin levels compared with controls (154.36 [28.16] vs 131.03 [26.55]; P Conclusions and relevance Our results demonstrate that, in AD, increased cerebrospinal fluid orexin levels are related to a parallel sleep deterioration, which appears to be associated with cognitive decline. Therefore, the orexinergic system seems to be dysregulated in AD, and its output and function appear to be overexpressed along the progression of the neurodegenerative process. This overexpression may result from an imbalance of the neurotransmitter networks regulating the wake-sleep cycle toward the orexinergic system promoting wakefulness.read more
Citations
More filters
Journal ArticleDOI
Sleep and Human Aging
TL;DR: Do older adults simply need less sleep, or rather, are they unable to generate the sleep that they still need?
Journal ArticleDOI
β-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation
Bryce A. Mander,Shawn M. Marks,Jacob W. Vogel,Vikram Rao,Brandon Lu,Jared M. Saletin,Sonia Ancoli-Israel,William J. Jagust,William J. Jagust,Matthew P. Walker,Matthew P. Walker +10 more
TL;DR: It is shown that β-amyloid burden in medial prefrontal cortex (mPFC) correlates significantly with the severity of impairment in NREM SWA generation, and this data implicate sleep disruption as a mechanistic pathway through which β-Amyloid pathology may contribute to hippocampus-dependent cognitive decline in the elderly.
Journal ArticleDOI
Association between circadian rhythms and neurodegenerative diseases.
Yue Leng,Yue Leng,Erik S. Musiek,Kun Hu,Francesco P. Cappuccio,Kristine Yaffe,Kristine Yaffe +6 more
TL;DR: Evidence from preliminary studies suggest that circadian rhythm disruptions, in addition to being a symptom of neurodegeneration, might also be a potential risk factor for developing Alzheimer's disease and related dementias, and Parkinson's disease, although large, longitudinal studies are needed to confirm this relationship.
Journal ArticleDOI
Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease?
Bryce A. Mander,Joseph R. Winer,William J. Jagust,William J. Jagust,Matthew P. Walker,Matthew P. Walker +5 more
TL;DR: A role for NREM sleep disruption as a novel factor linking cortical Aβ to impaired hippocampus-dependent memory consolidation and the possibility of sleep as a new treatment target in aging, affording preventative and therapeutic benefits is evaluated.
Journal ArticleDOI
Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms
Krista L. Lanctôt,Joan Amatniek,Sonia Ancoli-Israel,Steven E. Arnold,Clive Ballard,Clive Ballard,Jiska Cohen-Mansfield,Zahinoor Ismail,Constantine G. Lyketsos,David Miller,Erik S. Musiek,Ricardo S. Osorio,Paul B. Rosenberg,Andrew Satlin,David C. Steffens,Pierre N. Tariot,Lisa J. Bain,Maria C. Carrillo,James Hendrix,Heidi Jurgens,Brendon P. Boot +20 more
TL;DR: This review will explore the neurobiology of NPSs in AD and specific symptoms common in AD such as psychosis, agitation, apathy, depression, and sleep disturbances.
References
More filters
Journal ArticleDOI
The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann,Guy M. McKhann,David S. Knopman,Howard Chertkow,Bradley T. Hyman,Clifford R. Jack,Claudia H. Kawas,William E. Klunk,Walter J. Koroshetz,Jennifer J. Manly,Richard Mayeux,Richard C. Mohs,John C. Morris,Martin N. Rossor,Philip Scheltens,Maria C. Carrillo,Bill Thies,Sandra Weintraub,Creighton H. Phelps +18 more
TL;DR: The workgroup sought to ensure that the revised criteria would be flexible enough to be used by both general healthcare providers without access to neuropsychological testing, advanced imaging, and cerebrospinal fluid measures, and specialized investigators involved in research or in clinical trial studies who would have these tools available.
Journal ArticleDOI
Neuropathological stageing of Alzheimer-related changes.
Heiko Braak,Eva Braak +1 more
TL;DR: The investigation showed that recognition of the six stages required qualitative evaluation of only a few key preparations, permitting the differentiation of six stages.
Journal Article
The ten-twenty electrode system of the international federation
TL;DR: During the First International EEG Congress, London in 1947, it was recommended that Dr. Herbert H. Jasper study methods to standardize the placement of electrodes used in EEG (Jasper 1958).
Journal ArticleDOI
Sleep Drives Metabolite Clearance From the Adult Brain
Lulu Xie,Hongyi Kang,Qiwu Xu,Michael Chen,Yonghong Liao,Meenakshisundaram Thiyagarajan,John O’Donnell,Daniel J. Christensen,Charles Nicholson,Jeffrey J. Iliff,Takahiro Takano,Rashid Deane +11 more
TL;DR: It is reported that sleep has a critical function in ensuring metabolic homeostasis and convective fluxes of interstitial fluid increased the rate of β-amyloid clearance during sleep, suggesting the restorative function of sleep may be a consequence of the enhanced removal of potentially neurotoxic waste products that accumulate in the awake central nervous system.